Allianz Asset Management Gmb H Standard Biotools Inc. Transaction History

Allianz Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.87 - $2.78 $796,994 - $1.18 Million	426,200 New	426,200 $1.16 Million
Q4 2019 Feb 13, 2020	SELL	$2.3 - $5.12 $394,675 - $878,581	-171,598 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$4.63 - $12.15 $3.98 Million - $10.4 Million	-859,124 Reduced 83.35%	171,598 $794,000
Q2 2019 Aug 08, 2019	BUY	$11.49 - $14.17 $7.04 Million - $8.68 Million	612,774 Added 146.61%	1,030,722 $12.7 Million
Q1 2019 May 13, 2019	BUY	$8.47 - $14.36 $3.54 Million - $6 Million	417,948 New	417,948 $5.56 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.